Meridian Bioscience ROA 2006-2019 | VIVO

Current and historical return on assets (ROA) values for Meridian Bioscience (VIVO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Meridian Bioscience ROA for the three months ending September 30, 2019 was 10.10%.
Meridian Bioscience ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $0.02B $0.33B 8.34%
2019-06-30 $0.03B $0.32B 9.29%
2019-03-31 $0.03B $0.25B 10.70%
2018-12-31 $0.03B $0.25B 9.90%
2018-09-30 $0.02B $0.25B 9.09%
2018-06-30 $0.02B $0.25B 9.50%
2018-03-31 $0.02B $0.26B 6.79%
2017-12-31 $0.02B $0.25B 8.41%
2017-09-30 $0.02B $0.25B 8.43%
2017-06-30 $0.02B $0.25B 8.01%
2017-03-31 $0.03B $0.25B 11.50%
2016-12-31 $0.03B $0.25B 11.43%
2016-09-30 $0.03B $0.25B 13.46%
2016-06-30 $0.04B $0.26B 15.87%
2016-03-31 $0.04B $0.26B 17.37%
2015-12-31 $0.04B $0.19B 19.83%
2015-09-30 $0.04B $0.18B 19.53%
2015-06-30 $0.04B $0.18B 19.69%
2015-03-31 $0.04B $0.18B 19.69%
2014-12-31 $0.04B $0.18B 19.69%
2014-09-30 $0.03B $0.18B 19.18%
2014-06-30 $0.04B $0.18B 19.75%
2014-03-31 $0.04B $0.18B 20.54%
2013-12-31 $0.04B $0.18B 20.90%
2013-09-30 $0.04B $0.18B 22.06%
2013-06-30 $0.04B $0.17B 22.60%
2013-03-31 $0.04B $0.17B 22.40%
2012-12-31 $0.04B $0.16B 22.68%
2012-09-30 $0.04B $0.16B 22.12%
2012-06-30 $0.03B $0.16B 21.05%
2012-03-31 $0.03B $0.16B 19.81%
2011-12-31 $0.03B $0.16B 17.92%
2011-09-30 $0.03B $0.16B 17.25%
2011-06-30 $0.03B $0.16B 15.97%
2011-03-31 $0.02B $0.16B 15.56%
2010-12-31 $0.02B $0.16B 15.03%
2010-09-30 $0.03B $0.16B 17.02%
2010-06-30 $0.03B $0.15B 19.61%
2010-03-31 $0.03B $0.15B 21.60%
2009-12-31 $0.03B $0.16B 22.48%
2009-09-30 $0.03B $0.16B 22.15%
2009-06-30 $0.03B $0.15B 21.84%
2009-03-31 $0.03B $0.15B 21.42%
2008-12-31 $0.03B $0.15B 21.60%
2008-09-30 $0.03B $0.15B 21.31%
2008-06-30 $0.03B $0.14B 20.36%
2008-03-31 $0.03B $0.14B 21.68%
2007-12-31 $0.03B $0.14B 21.71%
2007-09-30 $0.03B $0.13B 21.47%
2007-06-30 $0.03B $0.13B 21.18%
2007-03-31 $0.02B $0.12B 18.33%
2006-12-31 $0.02B $0.12B 17.95%
2006-09-30 $0.02B $0.12B 16.63%
2006-06-30 $0.02B $0.12B 16.11%
2006-03-31 $0.02B $0.11B 15.50%
2005-12-31 $0.01B $0.11B 14.62%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.428B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.317B 22.01
Abbott Laboratories (ABT) United States $156.119B 28.48
Stryker (SYK) United States $78.360B 26.35
Boston Scientific (BSX) United States $60.213B 28.42
Baxter (BAX) United States $45.945B 27.86
Essilor Luxottica (ESLOY) France $34.669B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.600B 19.20
Lonza Group Ag (LZAGY) Switzerland $28.331B 0.00
Terumo (TRUMY) Japan $27.798B 34.69
Coloplast (CLPBY) Denmark $27.302B 42.13
ResMed (RMD) United States $23.111B 42.63
Smith & Nephew SNATS (SNN) United Kingdom $21.536B 0.00
Sunny Optical Technology (SNPTF) China $19.930B 0.00
Insulet (PODD) United States $11.836B 563.12
Bio-Rad Laboratories (BIO) United States $11.366B 54.56
Canopy Growth (CGC) Canada $8.470B 0.00
Perrigo (PRGO) Ireland $8.100B 15.10
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.790B 22.90
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 31.81
Haemonetics (HAE) United States $5.880B 39.73
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.131B 32.53
ICU Medical (ICUI) United States $3.896B 25.40
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.868B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.677B 61.18
Quidel (QDEL) United States $3.119B 29.60
Agios Pharmaceuticals (AGIO) United States $3.035B 0.00
National Vision Holdings (EYE) United States $2.590B 58.45
Aurora Cannabis (ACB) Canada $2.342B 0.00
Cardiovascular Systems (CSII) United States $1.844B 0.00
AtriCure (ATRC) United States $1.453B 0.00
InMode (INMD) Israel $1.430B 0.00
TG Therapeutics (TGTX) United States $1.397B 0.00
Aphria (APHA) $1.311B 0.00
VAREX IMAGING (VREX) United States $1.218B 24.35
NanoString Technologies (NSTG) United States $1.102B 0.00
Phibro Animal Health (PAHC) United States $1.058B 19.82
PetIQ (PETQ) United States $0.884B 21.56
Eagle Pharmaceuticals (EGRX) United States $0.814B 31.18
Lantheus Holdings (LNTH) United States $0.740B 18.49
LeMaitre Vascular (LMAT) United States $0.740B 41.57
Omeros (OMER) United States $0.736B 0.00
Quanterix (QTRX) United States $0.693B 0.00
Cerus (CERS) United States $0.589B 0.00
MacroGenics (MGNX) United States $0.567B 0.00
Surmodics (SRDX) United States $0.561B 58.15
Organigram Holdings (OGI) Canada $0.531B 0.00
OraSure Technologies (OSUR) United States $0.515B 30.93
HEXO (HEXO) $0.484B 0.00
Utah Medical Products (UTMD) United States $0.392B 28.40
Owens & Minor (OMI) United States $0.364B 13.47
Zynex (ZYXI) United States $0.346B 39.19
BioLife Solutions (BLFS) United States $0.325B 132.50
Bovie Medical (APYX) United States $0.286B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.272B 0.00
Female Health (VERU) United States $0.267B 0.00
Vapotherm (VAPO) United States $0.252B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Viemed Healthcare (VMD) United States $0.216B 22.80
Repro-Med Systems (KRMD) United States $0.215B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.188B 0.00
Rockwell Medical (RMTI) United States $0.182B 0.00
Liberty Health Sciences (LHSIF) Canada $0.175B 0.00
InfuSystems Holdings (INFU) United States $0.171B 861.00
Cytosorbents (CTSO) United States $0.151B 0.00
Fonar (FONR) United States $0.136B 9.59
Chimerix (CMRX) United States $0.127B 0.00
MTech Acquisition (KERN) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
United-Guardian (UG) United States $0.090B 22.83
MRI Interventions (MRIC) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.087B 0.00
Nephros (NEPH) United States $0.079B 0.00
Chembio Diagnostics (CEMI) United States $0.070B 0.00
FSD PHARMA INC (HUGE) $0.046B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.025B 0.00
Senestech (SNES) United States $0.017B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Myomo (MYO) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00